SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (351)11/12/2002 3:20:06 PM
From: Czechsinthemail  Read Replies (2) of 598
 
Nice to see the progress on oral Factor Xa. It sounds like they may have a significant market if it is able to make its way through trials and get approval.

A few questions:

1. Is this a joint development program with shared costs or is Lilly developing it and paying TLRK via milestones/royalties?

2. Any idea what the dollar impact of the milestone payments might be?

3. My recollection was that TLRK indicated they would be announcing a new collaboration this quarter. Since this is a new announcement on a collaboration, I'm wondering if I had misunderstood or if we should soon be getting word on a new collaboration.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext